This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 17 
1 out of 264 
Years Active: 2022
Title: Hye In Yum: Innovator in Anti-Cancer Antibodies
Introduction
Hye In Yum is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of anti-cancer agents.
Latest Patents
Hye In Yum holds a patent for an "Anti-CEACAM1 antibody and use thereof." This invention provides anti-CEACAM1 antibodies with improved binding abilities specific to CEACAM1. The antibodies exhibit superior binding abilities and activate the anti-cancer immune functions of cytotoxic T cells and natural killer cells. Consequently, these antibodies can be effectively used as anti-cancer agents and compositions for treating cancer.
Career Highlights
Throughout his career, Hye In Yum has worked with esteemed organizations such as the Mogam Institute for Biomedical Research and the Green Cross Corporation. His work has focused on advancing cancer treatment through innovative antibody development.
Collaborations
Hye In Yum has collaborated with notable colleagues, including So-Young Eun and Miyoung Oh, who have contributed to his research endeavors.
Conclusion
Hye In Yum's innovative work in developing anti-CEACAM1 antibodies showcases his commitment to advancing cancer treatment. His contributions to biomedical research are paving the way for new therapeutic options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile